The court filing for Massachusetts stated, "Purdue determined that opioid savings cards worked like the teaser rate on a long-term and very high-stakes mortgage."
The court document from Massachusetts stated that Purdue Pharmaceuticals believed opioid savings cards functioned similarly to a teaser rate on a long-term and very risky mortgage.